newsfilter
← Latest News
GlobeNewswire·

Eckert & Ziegler to Supply POINT Biopharma with Actinium-225

BERLIN and INDIANAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) -- Eckert & Ziegler (ISIN DE0005659700, TecDAX) and a subsidiary of POINT Biopharma Global Inc. (("POINT", NASDAQ:PNT) have signed an agreement on the supply